WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks losing its position as the global leader in biotechnology and what must be done to maintain and advance our lead in this critical field. In response, John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement:“The United States has been the global leader in biotechnology since the creation of this industry nearly 50 years ago, with innovative advances and breakthrough therapies that touch nearly every aspect of our lives. A strong and vibrant biotechnology industry is vitally important to public health, our economic strength and our national security.“But today, U.S. dominance in biotechnology is under great threat and our industry is at a crossroads. The NSCEB final report makes clear that without immediate and bold action, the U.S. will cede its dominance in biotech to China in the next few years. This cannot happen.“The report provides us with a roadmap to unlock private investment in biotechnology and protect the health and security of the American people for generations to come.“Working together, the U.S. government, academia and the private sector have the power to ensure that American biotech out-innovates the competition, grows our economy, and speeds progress that transforms scientific discoveries into real-world products and solutions.“BIO thanks the Commission for its tireless work in bringing these findings to light and underscoring what is at stake for the future of American biotechnology. We look forward to working with Congress and the Administration to advance and implement policies that will protect and advance America’s biotech leadership.”The full report, including the Commission’s comprehensive set of recommendations can be found on the…